These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11302874)

  • 1. Impaired catecholaminergic signalling of B lymphocytes in patients with chronic rheumatic diseases.
    Wahle M; Kölker S; Krause A; Burmester GR; Baerwald CG
    Ann Rheum Dis; 2001 May; 60(5):505-10. PubMed ID: 11302874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced catecholamine response of lymphocytes from patients with rheumatoid arthritis.
    Baerwald CG; Wahle M; Ulrichs T; Jonas D; von Bierbrauer A; von Wichert P; Burmester GR; Krause A
    Immunobiology; 1999 Feb; 200(1):77-91. PubMed ID: 10084697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 2-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatic diseases.
    Baerwald C; Graefe C; Muhl C; Von Wichert P; Krause A
    Eur J Clin Invest; 1992 Oct; 22 Suppl 1():42-6. PubMed ID: 1333966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
    Mitsuo A; Morimoto S; Nakiri Y; Suzuki J; Kaneko H; Tokano Y; Tsuda H; Takasaki Y; Hashimoto H
    Rheumatology (Oxford); 2006 Dec; 45(12):1477-84. PubMed ID: 16638798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
    Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
    Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis.
    Mavropoulos A; Simopoulou T; Varna A; Liaskos C; Katsiari CG; Bogdanos DP; Sakkas LI
    Arthritis Rheumatol; 2016 Feb; 68(2):494-504. PubMed ID: 26414243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases.
    Sfikakis PP; Charalambopoulos D; Vaiopoulos G; Mavrikakis M
    Clin Rheumatol; 1999; 18(1):28-32. PubMed ID: 10088945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclic AMP level in T- and B lymphocytes in patients with rheumatoid arthritis and systemic lupus erythematosus].
    Bandzhiulene SIu; Matulis AA
    Ter Arkh; 1986; 58(7):46-9. PubMed ID: 3020728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of beta2-adrenergic receptors on CD4 and CD8 positive lymphocytes by cytokines in vitro.
    Wahle M; Stachetzki U; Krause A; Pierer M; Häntzschel H; Baerwald CG
    Cytokine; 2001 Dec; 16(6):205-9. PubMed ID: 11884023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells.
    Sato S; Fujimoto M; Hasegawa M; Takehara K
    Arthritis Rheum; 2004 Jun; 50(6):1918-27. PubMed ID: 15188368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The abnormality of FcgammaRIIB1-mediated signaling and the hyperactivity of B cells from patients with systemic lupus erythematosus].
    Peng KJ; Xiao LS; Fei Y; Wang SR
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):769-71. PubMed ID: 17077019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
    Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
    Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
    Alexander T; Sattler A; Templin L; Kohler S; Groß C; Meisel A; Sawitzki B; Burmester GR; Arnold R; Radbruch A; Thiel A; Hiepe F
    Ann Rheum Dis; 2013 Sep; 72(9):1549-58. PubMed ID: 23264341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKCδ/ERK Signaling Pathway.
    He XJ; Ding Y; Xiang W; Dang XQ
    Cell Physiol Biochem; 2016; 40(3-4):743-756. PubMed ID: 27915349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.
    Colombo BM; Canevali P; Magnani O; Rossi E; Puppo F; Zocchi MR; Poggi A
    PLoS One; 2012; 7(2):e31903. PubMed ID: 22355402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunction of T cell receptor AV24AJ18+, BV11+ double-negative regulatory natural killer T cells in autoimmune diseases.
    Kojo S; Adachi Y; Keino H; Taniguchi M; Sumida T
    Arthritis Rheum; 2001 May; 44(5):1127-38. PubMed ID: 11352245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Apoptotic Microparticles in Systemic Lupus Erythematosus Patients Drive the Activation of Dendritic Cell Subsets and Prime Neutrophils for NETosis.
    Dieker J; Tel J; Pieterse E; Thielen A; Rother N; Bakker M; Fransen J; Dijkman HB; Berden JH; de Vries JM; Hilbrands LB; van der Vlag J
    Arthritis Rheumatol; 2016 Feb; 68(2):462-72. PubMed ID: 26360137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients.
    Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y
    J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.